Scholars@Duke
Cameron Robert Wolfe

Cameron Robert Wolfe

Professor of Medicine
Medicine, Infectious Diseases
cw74@duke.edu
Duke Box 102359, Division of Infectious Diseases, DUMC, Durham, NC 27710
Room 159 Hanes House, Trent Drive, Durham, NC 27710

Overview

HIV infection, Transplant-related infectious diseases, general infectious diseases, Biological and Emergency Preparedness for hospital systems, influenza and respiratory viral pathogens

Current Appointments & Affiliations

Professor of Medicine · 2023 - Present Medicine, Infectious Diseases, Medicine
Associate of the Duke Initiative for Science & Society · 2020 - Present Duke Science & Society, University Initiatives & Academic Support Units
Member of the Duke Human Vaccine Institute · 2022 - Present Duke Human Vaccine Institute, Institutes and Centers

In the News

Published December 11, 2025
Avoiding Viral Illness During the Holidays
Published September 6, 2023
What to Expect From COVID This Fall
Published May 10, 2023
A Duke Reflection on the Official End of the COVID-19 Public Health Emergency

View All News

Recent Publications

Antiviral clinical trial design throughout the COVID pandemic: evolving endpoints and lessons learnt.

Journal Article Curr Opin Infect Dis · February 1, 2026 PURPOSE OF REVIEW: Trial design during the novel coronavirus-19 (COVID-19) pandemic was stymied by significant uncertainty about the natural history of the virus, at-risk populations, and optimal patient care by investigators and clinicians alike. RECENT F ... Full text Link to item Cite

Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023-2024 Season.

Journal Article Clin Infect Dis · November 6, 2025 BACKGROUND: The 2023-2024 US influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with cocirculation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United States against mild-to-moderate ... Full text Link to item Cite

Laboratory Methods for Monitoring Influenza Antiviral Resistance.

Journal Article J Infect Dis · October 17, 2025 Monitoring antiviral susceptibility is an essential component of virologic surveillance conducted by laboratories participating in the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS). Since 2011, the WHO Expert Wor ... Full text Link to item Cite
View All Publications

Recent Grants

CISA 2023 Clinical Contributing Task 1

ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2028

CISA 2023 Clinical Contributing Task 2

ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2028

View All Grants

Education, Training & Certifications

University of Melbourne (Australia) · 2000 M.B.B.S.